NIH Office of Technology Transfer:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:NIH Office of Technology Transfer - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12381
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NIH Office of Technology Transfer (NIH OTT), a subsidiary of National Institutes of Health is a healthcare service provider that evaluates, protects, markets, licenses, monitors, and manages NIH and FDA discoveries, inventions, and other intellectual property. The center discovers new biological molecules, processes and pathways, medical technologies, and innovative applications to improve public health. It provides licensing and royalties that include licensing opportunities, royalties, startups, non-profit license, neglected diseases and rare diseases; initiating cooperative research and development agreements. NIH OTT transfers its medical knowledge from its laboratories to other organizations for the purpose of developing that knowledge into medical products. The center also offers training associated with technology transfer presentations and articles, intramural research training award fellowships, internship opportunities in federal technology transfer, and international training opportunities in federal technology transfer. NIH OTT is headquartered in Rockville, Maryland, the US.

NIH Office of Technology Transfer – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
NIH Office of Technology Transfer, Medical Devices Deals, 2012 to YTD 2018 9
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
KannaLife Sciences Enters Into Licensing Agreement With NIH 11
JSK Therapeutics Enters Into Licensing Agreement with NIH Office of Technology Transfer 12
KannaLife Sciences Enters Into Licensing Agreement With NIH-OTT 13
NIH Office of Technology Transfer – Key Competitors 14
NIH Office of Technology Transfer – Key Employees 15
NIH Office of Technology Transfer – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Key Facts 2
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NIH Office of Technology Transfer, Deals By Therapy Area, 2012 to YTD 2018 8
NIH Office of Technology Transfer, Medical Devices Deals, 2012 to YTD 2018 9
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
KannaLife Sciences Enters Into Licensing Agreement With NIH 11
JSK Therapeutics Enters Into Licensing Agreement with NIH Office of Technology Transfer 12
KannaLife Sciences Enters Into Licensing Agreement With NIH-OTT 13
NIH Office of Technology Transfer, Key Competitors 14
NIH Office of Technology Transfer, Key Employees 15

List of Figures
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NIH Office of Technology Transfer, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
NIH Office of Technology Transfer, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[NIH Office of Technology Transfer:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Allegiance Capital Corporation:企業の戦略・SWOT・財務分析
    Allegiance Capital Corporation - Strategy, SWOT and Corporate Finance Report Summary Allegiance Capital Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Arkema SA:企業のM&A・事業提携・投資動向
    Arkema SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Arkema SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Ingka Holding B.V.:企業の戦略・SWOT・財務情報
    Ingka Holding B.V. - Strategy, SWOT and Corporate Finance Report Summary Ingka Holding B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Kallpa Generacion SA:発電所・企業SWOT分析
    Kallpa Generacion SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Harbin Electric Co Ltd (1133):企業の財務・戦略的SWOT分析
    Harbin Electric Co Ltd (1133) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • AECOM (ACM):電力:M&Aディール及び事業提携情報
    Summary AECOM, formerly AECOM Technology Corporation, is a provider of engineering, consulting and project management services. The company primarily designs, builds, operates and finances various infrastructure assets for businesses, governments, and organizations. Its service offerings include ass …
  • Siemens Ltd (SIEMENS):企業の財務・戦略的SWOT分析
    Siemens Ltd (SIEMENS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ERBA Molecular Ltd:企業の製品パイプライン分析2018
    Summary ERBA Molecular Ltd (ERBA Molecular), formerly Lumora Ltd, a subsidiary of Erba Diagnostics Mannheim GmbH, is a medical equipment company that offers innovative molecular diagnostics. The company provides technology that is used in medical diagnostics, agricultural, livestock and crops, food …
  • Cardno Ltd:企業のM&A・事業提携・投資動向
    Cardno Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cardno Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Redx Pharma Plc (REDX):企業の財務・戦略的SWOT分析
    Summary Redx Pharma Plc (Redx Pharma), formerly Redx Pharma Ltd is a drug discovery and development company that develops early stage and small molecule therapeutics. The company’s pipeline products include inhibitors for oncology and anti-infectives for treatment of diseases that include influenza …
  • Neurocrine Biosciences Inc (NBIX)-製薬・医療分野:企業M&A・提携分析
    Summary Neurocrine Biosciences Inc (Neurocrine) discovers, develops and commercializes pharmaceutical products for the treatment of neurologic, psychiatric and endocrine related diseases and disorders. Its lead product, Ingrezza (valbenazine) capsule is a US FDA approved selective vesicular monoamin …
  • Performance Food Group:企業の戦略・SWOT・財務情報
    Performance Food Group - Strategy, SWOT and Corporate Finance Report Summary Performance Food Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • NV Energy Inc-エネルギー分野:企業M&A・提携分析
    Summary NV Energy, Inc. (NVE), an indirect subsidiary of Berkshire Hathaway Energy Company, is an energy company, which provides a wide range of energy services and products through its principal subsidiaries, Nevada Power Company and Sierra Pacific Power Company. It delivers electricity to a large …
  • Catalyst Biosciences Inc (CBIO):医療機器:M&Aディール及び事業提携情報
    Summary Catalyst Biosciences Inc (Catalyst Biosciences), formerly Targacept Inc, is a clinical-stage biopharmaceutical company that develops protease-based advanced medicines to treat hematological indications. The company specializes in hemostasis, with focus on subcutaneous prophylaxis of hemophil …
  • Development Bank of Japan Inc:企業の戦略・SWOT・財務情報
    Development Bank of Japan Inc - Strategy, SWOT and Corporate Finance Report Summary Development Bank of Japan Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • ASIT Biotech SA (ASIT):企業の財務・戦略的SWOT分析
    Summary ASIT Biotech SA (ASIT Biotech), formerly BioTech Tools SA is a clinical stage biopharmaceutical company that develops in-vitro and in-vivo biotech tools. The company develops and commercializes immunotherapy medicines for respiratory and food allergies using ASIT plus technology platform. It …
  • Primark Stores Ltd:企業の戦略・SWOT・財務分析
    Primark Stores Ltd - Strategy, SWOT and Corporate Finance Report Summary Primark Stores Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • ImmunoGen Inc (IMGN):企業の財務・戦略的SWOT分析
    ImmunoGen Inc (IMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mondi Plc (MNDI):企業の戦略的SWOT分析
    Mondi Plc (MNDI) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • GeNeuro SA (GNRO):企業の財務・戦略的SWOT分析
    Summary GeNeuro SA (GeNeuro) operates as a clinical stage pharmaceutical company that manufactures therapeutic product pipeline for disorders of the nervous system. The company provides treatments against inflammatory and degenerative disorders associated with endogenous retroviruses. GeNeuro develo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆